GlassScriptPhysician profile
David Pougatsch
NPI 1619271616
$12,063.88
in general payments reported to CMS, 2019-2025
33 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $723 · 2020: $2,195 · 2021: $3,613 · 2022: $1,634 · 2023: $1,127 · 2024: $1,828 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,898.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $3,219.79 | 2021-2023 | |
| Organogenesis INC. | $1,585.53 | 2019-2024 | Puraply |
| Musculoskeletal Transplant Foundation INC. | $1,187.01 | 2019-2021 | |
| Amgen INC. | $799.59 | 2024-2025 | Krystexxa |
| Inari Medical, INC. | $685.67 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Smith+Nephew, INC. | $613.94 | 2019-2024 | Grafix Pl, Stravix, Oasis |
| Integra Lifesciences Corporation | $598.51 | 2019-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Kerecis Limited | $484.91 | 2022 | |
| Orthofix Medical, INC. | $390.13 | 2025 | Physio-Stim, Tl-Hex Truelok Hexapod System |
| Stryker Corporation | $342.02 | 2024-2025 | Prophecy, Augment Injectable |
| Melinta Therapeutics, LLC | $279.64 | 2022-2023 | Kimyrsa |
| Advanced Oxygen Therapy INC. | $278.06 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Amniox Medical, INC. | $268.29 | 2020 | |
| Paratek Pharmaceuticals, INC. | $177.35 | 2024-2025 | Nuzyra |
| Angiodynamics, INC. | $153.39 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medela LLC | $141.56 | 2020 | |
| Paragon 28, INC. | $131.58 | 2023 | Portfolio |
| Medline Industries LP | $124.45 | 2019-2021 | |
| Tei Medical INC. | $116.68 | 2019 | |
| Cardiovascular Systems INC. | $71.84 | 2022 | |
| Aroa Biosurgery Incorporated | $71.43 | 2025 | |
| Kci USA, INC. | $68.19 | 2020-2021 | |
| Polarityte, INC. | $35.59 | 2019 | |
| Tela Bio, INC. | $35.16 | 2020 | |
| Novo Nordisk INC | $30.46 | 2024 | Rybelsus, Ozempic |
| Acell, INC. | $28.13 | 2020 | |
| Sanara Medtech INC. | $27.65 | 2021 | |
| Osiris Therapeutics INC. | $25.12 | 2019 | |
| Allergan, INC. | $21.14 | 2020 | |
| Tactile Systems Technology INC | $20.78 | 2019 | |
| Misonix INC | $19.63 | 2021 | |
| Celularity INC. | $18.00 | 2019 | |
| Avanos Medical | $12.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Pougatsch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.